{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:41:58Z","timestamp":1790520118920,"version":"4.1.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.semcancer.2011.09.009","type":"journal-article","created":{"date-parts":[[2011,9,18]],"date-time":"2011-09-18T21:10:15Z","timestamp":1316380215000},"page":"299-307","source":"Crossref","is-referenced-by-count":20,"title":["Unlocking the secrets of immunoglobulin receptors in mantle cell lymphoma: Implications for the origin and selection of the malignant cells"],"prefix":"10.1016","volume":"21","author":[{"given":"Andreas","family":"Agathangelidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Hadzidimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Rosenquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Stamatopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2011.09.009_bib0005","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/asheducation-2009.1.542","article-title":"Current treatment standards and emerging strategies in mantle cell lymphoma","author":"Dreyling","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.semcancer.2011.09.009_bib0010","series-title":"WHO classification of tumors of haemopoietic and lymphoid tissues","author":"SwerdlowC.E.","year":"2008"},{"issue":"January (1)","key":"10.1016\/j.semcancer.2011.09.009_bib0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","article-title":"Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era","volume":"117","author":"Perez-Galan","year":"2011","journal-title":"Blood"},{"issue":"July (4)","key":"10.1016\/j.semcancer.2011.09.009_bib0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MOH.0b013e328302c9c5","article-title":"Mantle cell lymphoma: advances in biology and therapy","volume":"15","author":"Smith","year":"2008","journal-title":"Curr Opin Hematol"},{"issue":"June (4656)","key":"10.1016\/j.semcancer.2011.09.009_bib0025","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1126\/science.6610211","article-title":"Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation","volume":"224","author":"Tsujimoto","year":"1984","journal-title":"Science"},{"issue":"April (6318)","key":"10.1016\/j.semcancer.2011.09.009_bib0030","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/350512a0","article-title":"A novel cyclin encoded by a bcl1-linked candidate oncogene","volume":"350","author":"Motokura","year":"1991","journal-title":"Nature"},{"issue":"May (9)","key":"10.1016\/j.semcancer.2011.09.009_bib0035","first-page":"1833","article-title":"Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma","volume":"10","author":"de Boer","year":"1995","journal-title":"Oncogene"},{"issue":"October (8)","key":"10.1016\/j.semcancer.2011.09.009_bib0040","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1182\/blood.V84.8.2726.2726","article-title":"PRAD-1\/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma","volume":"84","author":"Bosch","year":"1994","journal-title":"Blood"},{"issue":"August (15)","key":"10.1016\/j.semcancer.2011.09.009_bib0045","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1002\/j.1460-2075.1994.tb06655.x","article-title":"Cyclin D1\/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice","volume":"13","author":"Lovec","year":"1994","journal-title":"EMBO J"},{"issue":"October (10)","key":"10.1016\/j.semcancer.2011.09.009_bib0050","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc2230","article-title":"Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics","volume":"7","author":"Jares","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"May (5)","key":"10.1016\/j.semcancer.2011.09.009_bib0055","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/gcc.20754","article-title":"Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma","volume":"49","author":"Espinet","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"issue":"February (2)","key":"10.1016\/j.semcancer.2011.09.009_bib0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/gcc.20836","article-title":"High-resolution genomic screening in mantle cell lymphoma\u2014specific changes correlate with genomic complexity, the proliferation signature and survival","volume":"50","author":"Halldorsdottir","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"issue":"August (6)","key":"10.1016\/j.semcancer.2011.09.009_bib0065","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/blood-2010-01-263806","article-title":"Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling","volume":"116","author":"Hartmann","year":"2010","journal-title":"Blood"},{"issue":"December (13)","key":"10.1016\/j.semcancer.2011.09.009_bib0070","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","article-title":"Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling","volume":"106","author":"Fu","year":"2005","journal-title":"Blood"},{"issue":"June (12)","key":"10.1016\/j.semcancer.2011.09.009_bib0075","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1182\/blood-2007-10-118794","article-title":"Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas","volume":"111","author":"Wlodarska","year":"2008","journal-title":"Blood"},{"issue":"April (4)","key":"10.1016\/j.semcancer.2011.09.009_bib0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrc1589","article-title":"Mechanisms of B-cell lymphoma pathogenesis","volume":"5","author":"Kuppers","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.semcancer.2011.09.009_bib0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-230X(01)83004-9","article-title":"The occurrence and significance of V gene mutations in B cell-derived human malignancy","volume":"83","author":"Stevenson","year":"2001","journal-title":"Adv Cancer Res"},{"issue":"January (1405)","key":"10.1016\/j.semcancer.2011.09.009_bib0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1098\/rstb.2000.0751","article-title":"Somatic hypermutation and B-cell lymphoma","volume":"356","author":"Dunn-Walters","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"February (3)","key":"10.1016\/j.semcancer.2011.09.009_bib0095","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1182\/blood-2007-07-099564","article-title":"Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis","volume":"111","author":"Murray","year":"2008","journal-title":"Blood"},{"issue":"February (6)","key":"10.1016\/j.semcancer.2011.09.009_bib0100","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood-2010-07-155663","article-title":"Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities","volume":"117","author":"Chiorazzi","year":"2011","journal-title":"Blood"},{"issue":"May (10)","key":"10.1016\/j.semcancer.2011.09.009_bib0105","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1182\/blood-2002-11-3456","article-title":"Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations","volume":"101","author":"Camacho","year":"2003","journal-title":"Blood"},{"issue":"October (8)","key":"10.1016\/j.semcancer.2011.09.009_bib0110","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1182\/blood-2003-05-1383","article-title":"VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome","volume":"102","author":"Kienle","year":"2003","journal-title":"Blood"},{"issue":"June (12)","key":"10.1016\/j.semcancer.2011.09.009_bib0115","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","article-title":"A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease","volume":"101","author":"Orchard","year":"2003","journal-title":"Blood"},{"issue":"March (3)","key":"10.1016\/j.semcancer.2011.09.009_bib0120","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/modpathol.2008.199","article-title":"Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentity","volume":"22","author":"Schraders","year":"2009","journal-title":"Mod Pathol"},{"issue":"April (4)","key":"10.1016\/j.semcancer.2011.09.009_bib0125","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1600-0609.2002.01662.x","article-title":"Somatic hypermutation and V(H) gene usage in mantle cell lymphoma","volume":"68","author":"Thorselius","year":"2002","journal-title":"Eur J Haematol"},{"issue":"May (10)","key":"10.1016\/j.semcancer.2011.09.009_bib0130","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1182\/blood-2002-11-3479","article-title":"Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma","volume":"101","author":"Walsh","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.009_bib0515","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1182\/blood-2011-03-343434","article-title":"Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases","volume":"118","author":"Hadzidimitriou","year":"2011","journal-title":"Blood"},{"issue":"August (7)","key":"10.1016\/j.semcancer.2011.09.009_bib0140","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood-2010-03-275859","article-title":"High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations","volume":"116","author":"Wu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.009_bib0145","series-title":"52nd ASH annual meeting abstracts","article-title":"The composition of the B cell receptor repertoire in 7428 cases of chronic lymphocytic leukemia: one third stereotyped, two thirds heterogeneous\u2014what does this mean?","author":"Agathangelidis","year":"2010"},{"key":"10.1016\/j.semcancer.2011.09.009_bib0150","series-title":"52nd ASH annual meeting","article-title":"Over 30% of patients with splenic marginal zone lymphoma express distinctive antigen receptors utilizing a single immunoglogulin variable gene: implications for the origin and selection of the neoplastic cells","author":"Bikos","year":"2010"},{"issue":"January (1)","key":"10.1016\/j.semcancer.2011.09.009_bib0155","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/leu.2009.186","article-title":"A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence","volume":"24","author":"Darzentas","year":"2010","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.semcancer.2011.09.009_bib0160","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/intimm\/9.12.1801","article-title":"Evolution of the structural repertoire of the human V(H) and Vkappa germline genes","volume":"9","author":"Vargas-Madrazo","year":"1997","journal-title":"Int Immunol"},{"issue":"May (3)","key":"10.1016\/j.semcancer.2011.09.009_bib0165","first-page":"469","article-title":"Divergent evolution and evolution by the birth-and-death process in the immunoglobulin VH gene family","volume":"11","author":"Ota","year":"1994","journal-title":"Mol Biol Evol"},{"issue":"January (1)","key":"10.1016\/j.semcancer.2011.09.009_bib0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/oxfordjournals.molbev.a025846","article-title":"Evolution of immunoglobulin kappa chain variable region genes in vertebrates","volume":"15","author":"Sitnikova","year":"1998","journal-title":"Mol Biol Evol"},{"issue":"November (9)","key":"10.1016\/j.semcancer.2011.09.009_bib0175","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.4049\/jimmunol.151.9.5011","article-title":"Human antilipid A monoclonal antibodies bind to human B cells and the i antigen on cord red blood cells","volume":"151","author":"Bhat","year":"1993","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.semcancer.2011.09.009_bib0180","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/bcmd.1996.0020","article-title":"The V4-34 encoded anti-i autoantibodies recognize a large subset of human and mouse B-cells","volume":"22","author":"Silberstein","year":"1996","journal-title":"Blood Cells Mol Dis"},{"issue":"October (1)","key":"10.1016\/j.semcancer.2011.09.009_bib0185","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1365-2249.1998.00703.x","article-title":"Sequence analysis of V(4-34)-encoded antibodies from single B cells of two patients with systemic lupus erythematosus (SLE)","volume":"114","author":"Mockridge","year":"1998","journal-title":"Clin Exp Immunol"},{"issue":"December (12)","key":"10.1016\/j.semcancer.2011.09.009_bib0190","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1002\/eji.1830231240","article-title":"VH CDR3-dependent positive selection of murine VH12-expressing B cells in the neonate","volume":"23","author":"Clarke","year":"1993","journal-title":"Eur J Immunol"},{"issue":"March (4)","key":"10.1016\/j.semcancer.2011.09.009_bib0195","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00281-004-0188-9","article-title":"Human innate B cells: a link between host defense and autoimmunity?","volume":"26","author":"Milner","year":"2005","journal-title":"Semin Immunopathol"},{"issue":"October (7)","key":"10.1016\/j.semcancer.2011.09.009_bib0200","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1172\/JCI200112462","article-title":"Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance","volume":"108","author":"Pugh-Bernard","year":"2001","journal-title":"J Clin Invest"},{"issue":"July (1)","key":"10.1016\/j.semcancer.2011.09.009_bib0205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1074-7613(00)00006-6","article-title":"Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities","volume":"13","author":"Xu","year":"2000","journal-title":"Immunity"},{"issue":"January (1)","key":"10.1016\/j.semcancer.2011.09.009_bib0210","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/protein\/14.1.67","article-title":"A central core structure in an antibody variable domain determines antigen specificity","volume":"14","author":"Jirholt","year":"2001","journal-title":"Protein Eng"},{"issue":"November (3)","key":"10.1016\/j.semcancer.2011.09.009_bib0215","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/prot.22087","article-title":"Structural classification of CDR-H3 revisited: a lesson in antibody modeling","volume":"73","author":"Kuroda","year":"2008","journal-title":"Proteins"},{"issue":"July\u2013August (4)","key":"10.1016\/j.semcancer.2011.09.009_bib0220","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/jmr.679","article-title":"Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor","volume":"17","author":"Barrios","year":"2004","journal-title":"J Mol Recognit"},{"issue":"June (6)","key":"10.1016\/j.semcancer.2011.09.009_bib0225","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1172\/JCI24387","article-title":"Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity","volume":"115","author":"Herve","year":"2005","journal-title":"J Clin Invest"},{"issue":"November (11)","key":"10.1016\/j.semcancer.2011.09.009_bib0230","first-page":"12a","article-title":"B-cell chronic lymphocytic leukemia (B-CLL) cells express antibodies reactive with antigenic epitopes expressed on the surface of common bacteria","volume":"108","author":"Hatzi","year":"2006","journal-title":"Blood"},{"issue":"May (19)","key":"10.1016\/j.semcancer.2011.09.009_bib0235","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1182\/blood-2009-09-244251","article-title":"Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin","volume":"115","author":"Chu","year":"2010","journal-title":"Blood"},{"issue":"April (7)","key":"10.1016\/j.semcancer.2011.09.009_bib0240","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood-2007-11-125450","article-title":"A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies","volume":"111","author":"Lanemo Myhrinder","year":"2008","journal-title":"Blood"},{"issue":"December (13)","key":"10.1016\/j.semcancer.2011.09.009_bib0245","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1182\/blood-2008-06-162024","article-title":"Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA","volume":"112","author":"Chu","year":"2008","journal-title":"Blood"},{"issue":"January (1)","key":"10.1016\/j.semcancer.2011.09.009_bib0250","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","article-title":"Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations","volume":"109","author":"Stamatopoulos","year":"2007","journal-title":"Blood"},{"issue":"February (4)","key":"10.1016\/j.semcancer.2011.09.009_bib0255","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2141.2008.07469.x","article-title":"Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study","volume":"144","author":"Bomben","year":"2009","journal-title":"Br J Haematol"},{"issue":"June (2)","key":"10.1016\/j.semcancer.2011.09.009_bib0260","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2567.2001.01220.x","article-title":"Third complementarity-determining region of mutated VH immunoglobulin genes contains shorter V, D, J, P, and N components than non-mutated genes","volume":"103","author":"Rosner","year":"2001","journal-title":"Immunology"},{"issue":"December (4)","key":"10.1016\/j.semcancer.2011.09.009_bib0265","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jmb.2003.10.007","article-title":"Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures","volume":"334","author":"Zemlin","year":"2003","journal-title":"J Mol Biol"},{"issue":"December (12)","key":"10.1016\/j.semcancer.2011.09.009_bib0270","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/intimm\/10.12.1801","article-title":"Preferred CDRH3 lengths for antibodies with defined specificities","volume":"10","author":"Johnson","year":"1998","journal-title":"Int Immunol"},{"key":"10.1016\/j.semcancer.2011.09.009_bib0275","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.immunol.26.021607.090236","article-title":"The biochemistry of somatic hypermutation","volume":"26","author":"Peled","year":"2008","journal-title":"Annu Rev Immunol"},{"issue":"March (6)","key":"10.1016\/j.semcancer.2011.09.009_bib0280","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.4049\/jimmunol.172.6.3369","article-title":"Textbook germinal centers?","volume":"172","author":"Manser","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.semcancer.2011.09.009_bib0285","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.genet.41.110306.130340","article-title":"Immunoglobulin somatic hypermutation","volume":"41","author":"Teng","year":"2007","journal-title":"Annu Rev Genet"},{"issue":"November (11)","key":"10.1016\/j.semcancer.2011.09.009_bib0290","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/ni.1799","article-title":"A coming-of-age story: activation-induced cytidine deaminase turns 10","volume":"10","author":"Delker","year":"2009","journal-title":"Nat Immunol"},{"issue":"October (10)","key":"10.1016\/j.semcancer.2011.09.009_bib0295","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1002\/eji.200535134","article-title":"Human splenic marginal zone B cells lack expression of activation-induced cytidine deaminase","volume":"35","author":"Willenbrock","year":"2005","journal-title":"Eur J Immunol"},{"issue":"October (10)","key":"10.1016\/j.semcancer.2011.09.009_bib0300","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/eji.200535446","article-title":"Splenic marginal zone B cells in humans: where do they mutate their Ig receptor?","volume":"35","author":"Weller","year":"2005","journal-title":"Eur J Immunol"},{"issue":"September (5589)","key":"10.1016\/j.semcancer.2011.09.009_bib0305","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1126\/science.1073924","article-title":"Evolution of autoantibody responses via somatic hypermutation outside of germinal centers","volume":"297","author":"William","year":"2002","journal-title":"Science"},{"issue":"January (3)","key":"10.1016\/j.semcancer.2011.09.009_bib0310","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1073\/pnas.98.3.1166","article-title":"CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans","volume":"98","author":"Weller","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.semcancer.2011.09.009_bib0315","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1383-5742(03)00032-2","article-title":"Theoretical analysis of mutation hotspots and their DNA sequence context specificity","volume":"544","author":"Rogozin","year":"2003","journal-title":"Mutat Res Sep"},{"issue":"March (6)","key":"10.1016\/j.semcancer.2011.09.009_bib0320","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.4049\/jimmunol.172.6.3382","article-title":"Cutting edge: DGYW\/WRCH is a better predictor of mutability at G:C bases in Ig hypermutation than the widely accepted RGYW\/WRCY motif and probably reflects a two-step activation-induced cytidine deaminase-triggered process","volume":"172","author":"Rogozin","year":"2004","journal-title":"J Immunol"},{"issue":"November (1)","key":"10.1016\/j.semcancer.2011.09.009_bib0325","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0167-4781(92)90134-L","article-title":"Somatic hypermutagenesis in immunoglobulin genes II. Influence of neighbouring base sequences on mutagenesis","volume":"1171","author":"Rogozin","year":"1992","journal-title":"Biochim Biophys Acta"},{"issue":"May (9)","key":"10.1016\/j.semcancer.2011.09.009_bib0330","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1084\/jem.20042483","article-title":"Intricate targeting of immunoglobulin somatic hypermutation maximizes the efficiency of affinity maturation","volume":"201","author":"Zheng","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.semcancer.2011.09.009_bib0335","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-065X.1998.tb01434.x","article-title":"Monitoring and interpreting the intrinsic features of somatic hypermutation","volume":"April (162)","author":"Neuberger","year":"1998","journal-title":"Immunol Rev"},{"issue":"February (4)","key":"10.1016\/j.semcancer.2011.09.009_bib0340","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood.V99.4.1299","article-title":"Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course","volume":"99","author":"Algara","year":"2002","journal-title":"Blood"},{"issue":"June (6)","key":"10.1016\/j.semcancer.2011.09.009_bib0345","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/eji.1830270616","article-title":"Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression","volume":"27","author":"Kuppers","year":"1997","journal-title":"Eur J Immunol"},{"issue":"March (5)","key":"10.1016\/j.semcancer.2011.09.009_bib0350","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood.V95.5.1797.005k30_1797_1803","article-title":"Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas","volume":"95","author":"Lossos","year":"2000","journal-title":"Blood"},{"issue":"January (1)","key":"10.1016\/j.semcancer.2011.09.009_bib0355","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V89.1.219","article-title":"and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells","volume":"89","author":"Sahota","year":"1997","journal-title":"Blood"},{"issue":"July\u2013December (7\u201312)","key":"10.1016\/j.semcancer.2011.09.009_bib0360","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2119\/2005-00001.Stamatopoulos","article-title":"Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma","volume":"10","author":"Stamatopoulos","year":"2004","journal-title":"Mol Med"},{"issue":"June (6)","key":"10.1016\/j.semcancer.2011.09.009_bib0365","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0167-5699(00)01650-9","article-title":"Molecular insights into the immunopathogenesis of follicular lymphoma","volume":"21","author":"Stamatopoulos","year":"2000","journal-title":"Immunol Today"},{"issue":"September (6)","key":"10.1016\/j.semcancer.2011.09.009_bib0370","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"issue":"September (6)","key":"10.1016\/j.semcancer.2011.09.009_bib0375","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"issue":"March (7)","key":"10.1016\/j.semcancer.2011.09.009_bib0380","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1073\/pnas.92.7.2529","article-title":"Human autoantibody recognition of DNA","volume":"92","author":"Barbas","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.semcancer.2011.09.009_bib0385","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1191\/0961203302lu302rr","article-title":"Systematic analysis of sequences of anti-DNA antibodies--relevance to theories of origin and pathogenicity","volume":"11","author":"Rahman","year":"2002","journal-title":"Lupus"},{"issue":"November (20)","key":"10.1016\/j.semcancer.2011.09.009_bib0390","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM199911113412007","article-title":"Cellular origin of human B-cell lymphomas","volume":"341","author":"Kuppers","year":"1999","journal-title":"N Engl J Med"},{"issue":"April (8)","key":"10.1016\/j.semcancer.2011.09.009_bib0395","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood.V85.8.2176.bloodjournal8582176","article-title":"Analysis of VH genes used by neoplastic B cells in endemic Burkitt's lymphoma shows somatic hypermutation and intraclonal heterogeneity","volume":"85","author":"Chapman","year":"1995","journal-title":"Blood"},{"issue":"November (9)","key":"10.1016\/j.semcancer.2011.09.009_bib0400","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1182\/blood.V88.9.3562.bloodjournal8893562","article-title":"VH and VL gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection","volume":"88","author":"Chapman","year":"1996","journal-title":"Blood"},{"issue":"June (11)","key":"10.1016\/j.semcancer.2011.09.009_bib0405","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood.V91.11.4292","article-title":"Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression","volume":"91","author":"Ottensmeier","year":"1998","journal-title":"Blood"},{"issue":"December (12)","key":"10.1016\/j.semcancer.2011.09.009_bib0410","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1200\/JCO.1998.16.12.3822","article-title":"Ongoing somatic mutations and clonal expansions after cure of Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue B-cell lymphoma","volume":"16","author":"Thiede","year":"1998","journal-title":"J Clin Oncol"},{"issue":"November (10)","key":"10.1016\/j.semcancer.2011.09.009_bib0415","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1182\/blood.V92.10.3857","article-title":"VH gene analysis of primary cutaneous B-cell lymphomas: evidence for ongoing somatic hypermutation and isotype switching","volume":"92","author":"Aarts","year":"1998","journal-title":"Blood"},{"issue":"October (7)","key":"10.1016\/j.semcancer.2011.09.009_bib0420","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2002-01-0169","article-title":"V(H) gene analysis of splenic marginal zone lymphomas reveals diversity in mutational status and initiation of somatic mutation in vivo","volume":"100","author":"Zhu","year":"2002","journal-title":"Blood"},{"issue":"November (9)","key":"10.1016\/j.semcancer.2011.09.009_bib0425","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1182\/blood.V80.9.2326.2326","article-title":"Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation","volume":"80","author":"Bakkus","year":"1992","journal-title":"Blood"},{"issue":"April (4)","key":"10.1016\/j.semcancer.2011.09.009_bib0430","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1084\/jem.181.4.1507","article-title":"Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells","volume":"181","author":"Hashimoto","year":"1995","journal-title":"J Exp Med"},{"issue":"February (4)","key":"10.1016\/j.semcancer.2011.09.009_bib0435","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1182\/blood.V87.4.1586.bloodjournal8741586","article-title":"Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and diversification","volume":"87","author":"Dono","year":"1996","journal-title":"Blood"},{"issue":"September (5)","key":"10.1016\/j.semcancer.2011.09.009_bib0440","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1084\/jem.20011693","article-title":"Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification","volume":"196","author":"Gurrieri","year":"2002","journal-title":"J Exp Med"},{"issue":"May (5)","key":"10.1016\/j.semcancer.2011.09.009_bib0445","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/leu.2008.379","article-title":"Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors","volume":"23","author":"Kostareli","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2011.09.009_bib0450","series-title":"New biological prognostic markers in CLL","author":"Stamatopoulos","year":"2010"},{"issue":"March (6)","key":"10.1016\/j.semcancer.2011.09.009_bib0455","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1182\/blood.V99.6.2262","article-title":"Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia","volume":"99","author":"Tobin","year":"2002","journal-title":"Blood"},{"issue":"February (4)","key":"10.1016\/j.semcancer.2011.09.009_bib0460","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1182\/blood-2004-07-2606","article-title":"Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene","volume":"105","author":"Ghia","year":"2005","journal-title":"Blood"},{"issue":"April (7)","key":"10.1016\/j.semcancer.2011.09.009_bib0465","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1182\/blood-2005-06-2227","article-title":"Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status","volume":"107","author":"Thorselius","year":"2006","journal-title":"Blood"},{"issue":"January (2)","key":"10.1016\/j.semcancer.2011.09.009_bib0470","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1158\/1078-0432.CCR-09-1638","article-title":"Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features","volume":"16","author":"Bomben","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"December (12)","key":"10.1016\/j.semcancer.2011.09.009_bib0475","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3324\/haematol.2010.028639","article-title":"Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors","volume":"95","author":"Marincevic","year":"2010","journal-title":"Haematologica"},{"issue":"March (3)","key":"10.1016\/j.semcancer.2011.09.009_bib0480","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/modpathol.3800237","article-title":"Mantle cell lymphomas with clonal immunoglobulin V(H)3-21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin V(H) genes","volume":"18","author":"Thelander","year":"2005","journal-title":"Mod Pathol"},{"issue":"June (6)","key":"10.1016\/j.semcancer.2011.09.009_bib0485","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1080\/10428190801947559","article-title":"Molecular genetic characterization reveals new subsets of mantle cell lymphoma","volume":"49","author":"Thelander","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"July (2)","key":"10.1016\/j.semcancer.2011.09.009_bib0490","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/blood.V84.2.403.403","article-title":"Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle","volume":"84","author":"Hummel","year":"1994","journal-title":"Blood"},{"issue":"November (10)","key":"10.1016\/j.semcancer.2011.09.009_bib0495","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1182\/blood-2005-04-1511","article-title":"Immunoglobulin light chain repertoire in chronic lymphocytic leukemia","volume":"106","author":"Stamatopoulos","year":"2005","journal-title":"Blood"},{"issue":"March (6)","key":"10.1016\/j.semcancer.2011.09.009_bib0500","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1182\/blood-2006-07-037150","article-title":"A novel human B cell subpopulation representing the initial germinal center population to express AID","volume":"109","author":"Kolar","year":"2007","journal-title":"Blood"},{"issue":"April (7)","key":"10.1016\/j.semcancer.2011.09.009_bib0505","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.4049\/jimmunol.0803391","article-title":"Identification and characterization of a human CD5+ pre-naive B cell population","volume":"182","author":"Lee","year":"2009","journal-title":"J Immunol"},{"issue":"June (11)","key":"10.1016\/j.semcancer.2011.09.009_bib0510","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1182\/blood-2004-11-4284","article-title":"Identification and characterization of circulating human transitional B cells","volume":"105","author":"Sims","year":"2005","journal-title":"Blood"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X11000587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X11000587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T23:08:34Z","timestamp":1712876914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X11000587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":102,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1044579X11000587"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2011.09.009","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}